Company Filing History:
Years Active: 2017
Title: The Innovative Contributions of Romelia Del Carmen Salomon Ferrer
Introduction
Romelia Del Carmen Salomon Ferrer is a notable inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent. His work exemplifies the intersection of science and creativity, showcasing the potential of new compounds in medical applications.
Latest Patents
Romelia holds a patent for N-[2-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2H-1,2,4-thiadiazin-5-yl)-1,3-thiazol-4-yl] amides. This invention is directed towards compounds, tautomers, and pharmaceutically acceptable salts of the compounds, which are disclosed in the patent. The compounds have a specific structure that may have important implications in the pharmaceutical industry.
Career Highlights
Romelia is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to engage in cutting-edge research and development, contributing to the advancement of medical science. His patent reflects his dedication to innovation and the pursuit of new therapeutic solutions.
Collaborations
Throughout his career, Romelia has collaborated with esteemed colleagues, including Michael Aaron Brodney and Christopher Ryan Butler. These collaborations highlight the importance of teamwork in the field of research and development, fostering an environment where innovative ideas can flourish.
Conclusion
Romelia Del Carmen Salomon Ferrer is a distinguished inventor whose work in pharmaceuticals has the potential to impact the industry significantly. His patent and collaborations demonstrate his commitment to advancing medical science through innovation.